Nephrocalcin Explained
Nephrocalcin is an acidic glycoprotein, is produced by renal proximal tubule cells. It inhibits crystal nucleation, growth and aggregation.[1] It is one of the key inhibitors for Nephrolithiasis, kidney stone disease.[2]
There are at least 4 known isoforms of Nephrocalcin: NC-A, NC-B, NC-C, and NC-D.[3] A higher secretion of NC-C and NC-D is found in kidney stone patients, whereas a higher secretion of NC-A and NC-B in non-patients.
Notes and References
- Asplin . J. . DeGanello . S. . Nakagawa . Y. N. . Coe . F. L. . November 1991 . Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals . The American Journal of Physiology . 261 . 5 Pt 2 . F824–830 . 10.1152/ajprenal.1991.261.5.F824 . 0002-9513 . 1951713.
- Negri . A. L. . Spivacow . F. R. . 2023-03-25 . Kidney stone matrix proteins: Role in stone formation . World Journal of Nephrology . en . 12 . 2 . 21–28 . 10.5527/wjn.v12.i2.21 . free . 37035509 . 10075018 .
- Nakagawa . Y. . March 1997 . Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion . The Keio Journal of Medicine . 46 . 1 . 1–9 . 10.2302/kjm.46.1 . 0022-9717 . 9095576. free .